Tyme Technologies, Inc. (NASDAQ: TYME) management will present at the 2019 Cross-Border Healthcare Winter Summit on Tuesday, December 10, 2019. The Company will present its corporate overview for 2019 with a special focus on growth opportunities driven by advances in the science of cancer metabolism, recently launched pivotal trial in pancreatic cancer and expanding clinical plans for its lead candidate SM-88 (racemetyrosine) in pancreatic, prostate, sarcoma, breast and hematological cancers.
Event: 2019 Cross-Border Healthcare Winter Summit
Place: New York City
Presentation Date: December 10, 2019
Presentation Time: 2:00 PM ET